Modality-specific
Biologics, ADCs, oligonucleotides, viral vectors and cell therapies each demand different manufacturing instincts.

Process, analytics and manufacturing quietly decide whether a program can scale. We place technical leaders who have taken products from bench to GMP and managed the CDMO relationships that make it possible.
Can you make it, reliably, at the scale patients will need? The specialists who connect a promising product with reliable supply.
Process and analytical development, manufacturing science, CDMO management, supply chain and technical leadership.
Biologics, ADCs, oligonucleotides, viral vectors and cell therapies each demand different manufacturing instincts.
Most emerging companies manufacture externally. We hire people who can lead a CDMO, not only work inside a plant.
The CMC leader you need for Phase 1 supply differs from the one who readies a commercial process. We plan for both.

Executive Search for leadership appointments, Hybrid Search for critical director-level hires, Contract & Interim for filings, readouts and gaps, and Team Build when you are creating the function.
Clinical-stage rare disease biotech · Series C
Clinical-stage oncology biotech · Series C
Clinical-stage gene therapy company · Public, small cap
A senior partner will respond within one business day.